These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30896454)

  • 1. Intrathecal therapy for pain in cancer patients.
    Dupoiron D
    Curr Opin Support Palliat Care; 2019 Jun; 13(2):75-80. PubMed ID: 30896454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain.
    Webster LR; Fakata KL; Charapata S; Fisher R; MineHart M
    Pain Med; 2008 Apr; 9(3):282-90. PubMed ID: 18366508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain.
    Wallace MS; Kosek PS; Staats P; Fisher R; Schultz DM; Leong M
    Pain Med; 2008 Apr; 9(3):271-81. PubMed ID: 18366507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal combination of ziconotide and morphine for refractory cancer pain: a rapidly acting and effective choice.
    Alicino I; Giglio M; Manca F; Bruno F; Puntillo F
    Pain; 2012 Jan; 153(1):245-249. PubMed ID: 22082570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
    Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal Drug Delivery.
    De Andrés J; Rubio-Haro R; De Andres-Serrano C; Asensio-Samper JM; Fabregat-Cid G
    Methods Mol Biol; 2020; 2059():75-108. PubMed ID: 31435916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal therapy: what has changed with the introduction of ziconotide.
    Kress HG; Simpson KH; Marchettini P; Ver Donck A; Varrassi G
    Pain Pract; 2009; 9(5):338-47. PubMed ID: 19740270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal ziconotide and opioid combination therapy for noncancer pain: an observational study.
    Deer TR; Kim C; Bowman R; Tolentino D; Stewart C; Tolentino W
    Pain Physician; 2009; 12(4):E291-6. PubMed ID: 19668287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Outcomes Using Intrathecal Drug Delivery Systems in Complex Regional Pain Syndrome.
    Herring EZ; Frizon LA; Hogue O; Mejia JU; Rosenquist R; Bolash RB; Machado AG; Nagel SJ
    Pain Med; 2019 Mar; 20(3):515-520. PubMed ID: 29889241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of two consecutive intrathecal catheter tip granulomas within nine months.
    Hoederath P; Gautschi OP; Land M; Hildebrandt G; Fournier JY
    Cent Eur Neurosurg; 2010 Feb; 71(1):39-42. PubMed ID: 20201126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ziconotide: A rapid detoxification protocol for the conversion from intrathecal morphine--the Raffaeli Detoxification Model.
    Raffaeli W; Righetti D; Sarti D; Balestri M; Ferioli I; Monterubbianesi MC; Caminiti A
    J Opioid Manag; 2011; 7(1):21-6. PubMed ID: 21434581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal Drug Delivery and Spinal Cord Stimulation for the Treatment of Cancer Pain.
    Xing F; Yong RJ; Kaye AD; Urman RD
    Curr Pain Headache Rep; 2018 Feb; 22(2):11. PubMed ID: 29404792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ziconotide: an update and review.
    Williams JA; Day M; Heavner JE
    Expert Opin Pharmacother; 2008 Jun; 9(9):1575-83. PubMed ID: 18518786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options.
    Deer TR; Pope JE; Hanes MC; McDowell GC
    Pain Med; 2019 Apr; 20(4):784-798. PubMed ID: 30137539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of a Cancer Patient with an Intrathecal Drug Delivery System and an Acute Brain Abscess.
    Walega DR; Korn M
    J Palliat Med; 2018 May; 21(5):727-729. PubMed ID: 29649397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A safety review of approved intrathecal analgesics for chronic pain management.
    Chalil A; Staudt MD; Harland TA; Leimer EM; Bhullar R; Argoff CE
    Expert Opin Drug Saf; 2021 Apr; 20(4):439-451. PubMed ID: 33583318
    [No Abstract]   [Full Text] [Related]  

  • 17. Intrathecal Drug Delivery Systems for Refractory Pancreatic Cancer Pain: Observational Follow-up Study Over an 11-Year Period in a Comprehensive Cancer Center.
    Carvajal G; Dupoiron D; Seegers V; Lebrec N; Boré F; Dubois PY; Leblanc D; Delorme T; Jubier-Hamon S
    Anesth Analg; 2018 Jun; 126(6):2038-2046. PubMed ID: 29543644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for Prospective Assays of Intrathecal Mixtures Including Morphine, Ropivacaine and Ziconotide: Prevention of Adverse Events and Feasibility in Clinical Practice.
    Dupoiron D; Devys C; Bazin C; Folliard C; Lebrec N; Boré F; Dubois PY; Kieffer H
    Pain Physician; 2015; 18(4):349-57. PubMed ID: 26218938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ziconotide--a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain--a short review.
    Klotz U
    Int J Clin Pharmacol Ther; 2006 Oct; 44(10):478-83. PubMed ID: 17063978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ziconotide: a clinical update and pharmacologic review.
    Pope JE; Deer TR
    Expert Opin Pharmacother; 2013 May; 14(7):957-66. PubMed ID: 23537340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.